The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus-Reference-Cited by-同舟云学术

The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus

Published:2010-12 Issue:2 Volume:10 Page:108-111
ISSN:1568-9972
Container-title:Autoimmunity Reviews
language:en
Short-container-title:Autoimmunity Reviews

Author:

Galarza-Maldonado Claudio,Kourilovitch María R.,Molineros Julio E.,Cardiel Mario H.,Zurita Luis,Soroka Nikolay F.,Yagur Viktor Y.,Doukh Natalia,Cervera Ricard

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference38 articles.

1. Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial;Goekoop-Ruiterman;Ann Intern Med,2007

2. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention;Landewé;Arthritis Rheum,2002

3. Treatment of systemic lupus erythematosus;Mosca;Int Immunopharmacol,2001

4. Immunotherapy of systemic lupus erythematosus;O'Neill;Autoimmun Rev,2005

5. Newer therapeutic approaches for systemic lupus erythematosus: immunosuppressive agents;Dooley;Rheum Dis Clin North Am,2006

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab as Treatment for Lupus Nephritis;JCR: Journal of Clinical Rheumatology;2024-07-03

2. Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations;Lupus Science & Medicine;2024-05

3. Seguimiento de la actividad clínica y del daño orgánico acumulado en una cohorte de pacientes con lupus eritematoso sistémico de la península de Yucatán, México (1995-2016);Reumatología Clínica;2023-02

4. Follow-up of clinical activity and accumulated organic damage in a cohort of patients with systemic lupus erythematosus from the Yucatán Peninsula, Mexico (1995–2016);Reumatología Clínica (English Edition);2023-02

5. The phenotype of CD3–CD56bright and CD3–CD56dim natural killer cells in systemic lupus erythematosus patients and its relation to disease activity;Rheumatology;2022-08-31